Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma. - Wikidata - wikimedia - TriplyDB

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.

http://www.wikidata.org/entity/Q34580487

about

Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.FGF2 and EGF Are Required for Self-Renewal and Organoid Formation of Canine Normal and Tumor Breast Stem Cells.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.A correlation study of the expression of HA-CD44st and HER-2 in breast cancer

P2860

Q37641518-69C73491-D1B6-4515-BC3C-D1808CE16D62 Q37686006-31B1A98C-F42C-422C-86F7-E5A0154CC6B9 Q40953798-3AC5004D-0390-4512-998E-F60CCF9D8CEC Q46489079-9EA77523-E365-4A73-AAD0-2C3BBB6F241F Q49887925-04DE48FA-1619-4E1A-94D6-F5E6177E23AA Q58754066-B7977C29-AB98-4F77-AB08-29E7BED13F60

P2860

Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.

http://www.wikidata.org/entity/Q34580487

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Correlation between epidermal ...... ast invasive ductal carcinoma.

@ast

Correlation between epidermal ...... ast invasive ductal carcinoma.

@en

Correlation between epidermal ...... ast invasive ductal carcinoma.

@nl

type

label

Correlation between epidermal ...... ast invasive ductal carcinoma.

@ast

Correlation between epidermal ...... ast invasive ductal carcinoma.

@en

Correlation between epidermal ...... ast invasive ductal carcinoma.

@nl

prefLabel

Correlation between epidermal ...... ast invasive ductal carcinoma.

@ast

Correlation between epidermal ...... ast invasive ductal carcinoma.

@en

Correlation between epidermal ...... ast invasive ductal carcinoma.

@nl

P1433

Q34580487-4910D9AB-BBDE-4DFF-B317-394C2B349DB7

P1476

Q34580487-44B0768A-D0FC-4F07-8B46-FA797FD4B5A2

P2093

Q34580487-0FC6A985-7137-4679-A05A-254F206BBED0

Q34580487-19960FCB-D35D-4973-A61B-677D2581205C

Q34580487-491E70D1-9C78-4854-8A1C-4A73F91D2750

Q34580487-841BFCCA-A365-48BE-A360-A8DD55E196B7

Q34580487-87401216-61D5-408E-B243-206DB6FDD20B

Q34580487-94278591-CDDB-4B3B-BACC-5AAB6A0BF09B

Q34580487-FD1ECA80-9CA9-41E0-9F11-137DF7DDBFB2

Q34580487-FD7DCE4C-7F16-4971-B343-BC51A5AFA1F4

P2860

Q34580487-0946C588-5AC2-4193-8CE7-A124E07316B3

Q34580487-0EB15AAC-B067-4BB7-8858-3E33D3B2A14F

Q34580487-135622A7-1103-4E2A-A0B6-C0974A5AABDD

Q34580487-1D4B3C48-CD23-40EF-A0B4-60DC77AD03CC

Q34580487-20C234C0-C8FF-436A-903A-465CFD16B7A9

Q34580487-2FA859AE-FE4A-495D-B50B-7D519C4BA0D4

Q34580487-5480AFF2-4813-45BA-8FC3-E7B294940DF1

Q34580487-634163F8-FDFA-475C-ACEA-D981EA022046

Q34580487-66C44EC7-EC5B-4C26-8191-0C822A983447

Q34580487-6D8787BD-7143-498D-B4C8-3FB042538968

P2888

Q34580487-6A75D9A5-68CD-4D18-BB23-D1822ABEC902

P304

Q34580487-8B7DF090-C6E8-48D1-8487-F7154586E2F4

P31

Q34580487-A419CCDB-49A5-4082-8EC5-AB0E8B19BEEB

P356

Q34580487-95366785-9DB6-4C1E-9F8A-333D95A62276

P433

Q34580487-CAEF25AE-D6DD-4B61-ADA5-2D37B328844E

P478

Q34580487-64BBF335-0D1B-4C55-8704-D64398DBB371

P577

Q34580487-7A578F09-EDC0-4C9A-B618-1233AA96CC61

P5875

Q34580487-981A61D7-1B03-4217-BAFA-982B6A58A3FB

P6179

Q34580487-4CD7A4B4-7F4E-42F8-B8DE-CED1FA13B748

P698

Q34580487-120DFC41-2DEC-416B-9868-2B49BB008763

P932

Q34580487-88267BF0-5356-4E24-B85B-A720AD564C41

P356

S12032-014-0275-2

P1433

Medical Oncology

P1476

Correlation between epidermal ...... ast invasive ductal carcinoma.

@en

P2093

Huiwen Weng

http://www.w3.org/2001/XMLSchema#string

Jiaxing Zhang

http://www.w3.org/2001/XMLSchema#string

Lily Yang

http://www.w3.org/2001/XMLSchema#string

Luanjing Zhang

http://www.w3.org/2001/XMLSchema#string

Nan Shao

http://www.w3.org/2001/XMLSchema#string

Sheng Ye

http://www.w3.org/2001/XMLSchema#string

Wen Li

http://www.w3.org/2001/XMLSchema#string

Zhousan Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Comprehensive molecular portraits of human breast tumours

Prospective identification of tumorigenic breast cancer cells

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

Clinical breast cancer, new developments in selection and endocrine treatment of patients.

Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatme

ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells

Triple-negative breast cancer: clinical features and patterns of recurrence.

Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.

P2888

s12032-014-0275-2

P304

275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0275-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268877573

http://www.w3.org/2001/XMLSchema#string

P6179

1030207851

http://www.w3.org/2001/XMLSchema#string

P698

25429827

http://www.w3.org/2001/XMLSchema#string

P932

4246130

http://www.w3.org/2001/XMLSchema#string